ey0018.9-1 | Cancer treatment and the risk of second neoplasia | ESPEYB18
NMY Journy
, WS Zrafi
, S Bolle
, B Fresneau
, C Alapetite
, RS Allodji
, D Berchery
, N Haddy
, I Kobayashi
, M Labbe
, H Pacquement
, C Pluchart
, B Schwartz
, V Souchard
, C Thomas-Teinturier
, C Veres
, G Vu-Bezin
, I Diallo
, F de Vathaire
Cancer Epidemiol Biomarkers Prev. 2021; 30: 133141. https://pubmed.ncbi.nlm.nih.gov/33033142/This retrospective study of 152 patients and 604 matched-controls within the FCCSS (French Childhood Cancer Survivor Study) cohort aimed to identify clinical and therapeutic factors associated with long-term risk of subsequent primary neoplasm (SPN) in the central nervous system (CNS), occurri...